Kabra Drugs informs about revised unaudited results

06 Mar 2024 Evaluate
Kabra Drugs has informed that it enclosed Revised Unaudited Result for the December Quarter with Limited Review.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

28.64 0.86 (3.10%)
19-Jan-2026 14:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1684.00
Dr. Reddys Lab 1175.05
Cipla 1393.30
Zydus Lifesciences 872.95
Lupin 2179.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×